IFNG and infection: However, the group immunized with 40 μg of the vaccine prototype (G2–40) presented significantly higher IFN-γ levels on days 15 and 18 after the booster, corresponding to days 0 and 3 post-challenge, respectively, than did the control group, indicating an early cellular response to infection (p < 0.05; two-way ANOVA).